35
staff
Hadly Clark
Hadly Clark is an associate director in FasterCures at the Milken Institute. She is an experience
d health professional focused on the intersection of health and technology.
+ Read More
staff
Janet Woodcock
Janet Woodcock, MD, was named acting commissioner of food and drugs on January 20, 2021.
staff
Richard Moscicki
Richard (Rich) A. Moscicki, MD, is the executive vice president for science and regulatory advoca
cy and the chief medical officer at Pharmaceutical Research and Manufacturers of America (PhRMA).
+ Read More
staff
Mohit Joshi
Mohit Joshi is a President of the company.
staff
Lou Maiuri
Lou Maiuri is Chief Operating Officer for State Street Corporation. In this role, he is responsib
le for our IT, Global Delivery, Charles River Development (CRD), State Street Global Exchange and Global Markets organizations.
+ Read More
staff
Madeleine Dassule
report
Envisioning a Trusted System for Health Data Accelerating Medical Research
Technological innovation in the health landscape is occurring rapidly, and much of it would not be
possible without patient data.
+ Read More
report
Future of Work: Insights for 2021 and Beyond
The COVID-19 pandemic has been a double-whammy for inequality: The worst-off have been hit hardest
while economy-wide digitalization has only exacerbated the skills gap.
+ Read More
report
Better Brain Health through Equity: Addressing Health and Economic Disparities in Dementia for African Americans and Latinos
'Better Brain Health through Equity: Addressing Health and Economic Disparities in Dementia for Afr
ican Americans and Latinos' centers around two overarching themes: (1) Strengthening the infrastructure among health-care, long-term care, and community-b
+ Read More
report
The Yen Sets, but Does the Sun Rise? Abenomics and the Future of Japan
Often described as the "three-arrow policy," Abenomics—the term coined to represent Japan’s Prime M
inister Shinzo Abe’s economic policies—has included aggressive steps designed to break the grip of deflation.
+ Read More
panel
Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedica
l innovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
video
A Conversation on Digitalization and the Future of Asset Management
Thursday, March 4 from 8 am to 9 am PT